Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Costeffectiveness of diagnostic tests.

A I Mushlin1, H S Ruchlin, M A Callahan

  • 1Department of Public Health, Weill Medical College of Cornell University, NY 10021, USA. aim2001@mail.med.cornell

Lancet (London, England)
|October 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examining Timeliness of Total Knee Replacement Among Patients with Knee Osteoarthritis in the U.S.: Results from the OAI and MOST Longitudinal Cohorts.

The Journal of bone and joint surgery. American volume·2020
Same author

Letters to the editors.

Journal of general internal medicine·2016
Same author

Cost-effectiveness of CT angiography and perfusion imaging for delayed cerebral ischemia and vasospasm in aneurysmal subarachnoid hemorrhage.

AJNR. American journal of neuroradiology·2014
Same author

Appropriate use of CT perfusion following aneurysmal subarachnoid hemorrhage: a Bayesian analysis approach.

AJNR. American journal of neuroradiology·2013
Same author

Evaluating CT perfusion using outcome measures of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.

AJNR. American journal of neuroradiology·2012
Same author

Using quantitative CT perfusion for evaluation of delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage.

AJNR. American journal of neuroradiology·2011
Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026
Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
See all related articles

Cost-effectiveness analysis of diagnostic tests is crucial for healthcare resource allocation. Evaluating diagnostic strategies ensures optimal value and improved patient outcomes in medicine.

Area of Science:

  • Health Economics
  • Medical Decision Making
  • Diagnostic Technology Assessment

Background:

  • Cost-effectiveness analysis (CEA) is vital for evaluating healthcare interventions.
  • Diagnostic tests present unique challenges in economic assessments compared to therapeutics.
  • Uncertainty in linking diagnostic results to patient outcomes complicates CEA.

Purpose of the Study:

  • To review the principles of CEA for diagnostic tests and procedures.
  • To illustrate CEA methods using clinical examples.
  • To demonstrate the utility of CEA results for healthcare decision-makers.

Main Methods:

  • Review of cost-effectiveness analysis principles for diagnostics.
  • Application of CEA methods to two clinical case studies: early multiple sclerosis and Helicobacter pylori testing.

Related Experiment Videos

  • Discussion of how CEA findings inform clinical and policy decisions.

    • Main Results:

    • Economic assessments of diagnostic tests are more complex than those for treatments.
    • CEA provides a framework for understanding the value of diagnostic services.
    • Decision-making for diagnostic test provision and utilization can be guided by CEA.

    Conclusions:

    • CEA is essential for maximizing value from limited healthcare resources.
    • Understanding the relationship between diagnosis and outcomes is key to accurate diagnostic CEA.
    • Economic evaluations of diagnostic technologies are increasingly important in modern healthcare.